Tookad (padeliporfin) is a small molecule pharmaceutical. Padeliporfin was first approved as Tookad on 2017-11-10. It has been approved in Europe to treat prostatic neoplasms.
Trade Name |
Tookad |
Common Name |
Padeliporfin |
Indication |
prostatic neoplasms |
Drug Class |
Benzoporphyrin derivatives |